x

Economy

Turkey Approves China-Based Sinovac Vaccine’s Emergency Use

January 13, 2021

ANKARA — Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China's Sinovac Biotch Ltd. on Wednesday, paving the way for the rollout for Turkey's vaccination program starting with health care workers and other high-risk groups.

The country's health minister and members of the country's scientific advisory council received the first shots live on television, soon after the health regulatory authority, the Turkish Medicines and Medical Devices Agency, announced it had given its approval for CoronaVac's emergency use in the country of 83 million.

"I had previously said that there is light at the end of the tunnel," Koca said as he received the first dose of the vaccine, which will be delivered in two doses. "I believe that the days ahead of us will be bright."

Koca said Turkey's vaccination program would begin on Thursday, starting with health care workers. He urged all citizens to be vaccinated, saying it was the most promising way to beat the pandemic.

The shots would carry a QR code assigned to a person's name in accordance with Ankara's vaccination program and an online appointment system.

The Sinovac vaccine underwent clinical trials in Turkey, Brazil and Indonesia, which have all reported diverging efficacy rates.

In December, Turkish authorities announced an efficacy rate of 91.25% from interim analysis of 29 cases in a trial with 7,371 volunteers. About 12,450 volunteers, including 1,500 health care workers, are involved in the late-stage clinical trials.

This week, Indonesia which, conducted its own Phase III clinical trials of the vaccine with 1,620 volunteers, announced a efficacy rate of 65.3%. 

Brazil's Instituto Butantan said last week that the vaccine was 78% effective in mild cases and 100% effective against severe and moderate infections based on 220 COVID-19 cases from 13,000 volunteers. 

The first shipment Sinovac vaccine, consisting of 3 million doses, arrived in Turkey late last month. Turkey is scheduled to receive a total of 50 million doses.

Turkey had previously also announced that it has agreed to procure 4.5 million doses of the vaccine developed by Pfizer and BioNTech, with an option to procure 30 million more doses later, although President Recep Tayyip Erdogan said on Monday that talks with BioNTech were ongoing.

Turkey has reported about 2.34 million infections and around 23,000 deaths.

The country has imposed weekend lockdowns and evening curfews to fight the surge in the cases.

RELATED

ATHENS - With the economy accelerating, Greece plans to make an early repayment of 8 billion euros ($8.

Top Stories

Columnists

A pregnant woman was driving in the HOV lane near Dallas.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

Video

1 of 2 Abducted Louisiana Children is Found Dead in Mississippi after Their Mother is Killed

JACKSON, Miss. (AP) — A Louisiana woman was found dead in her home Thursday, and her two young daughters were abducted and found hours later in Mississippi — one dead and the other alive, police said.

ATHENS – Acknowledging disappointing results in the European Parliament elections for New Democracy, Prime Minister Kyriakos Mitsotakis said there won’t be early elections in Greece and dismissed any idea of taking New Democracy further right.

NEW YORK – This year, Leros New York is the standout team in the Premier Division of the Long Island Soccer Football League (LISFL) – and beyond.

ROME - There were multiple triumphs for Greece this week at at the European Athletics Championships in Rome.

LAUSANNE, Switzerland (AP) — The Spanish team for men's soccer at the Paris Olympics got permission Thursday from the IOC to select two players who previously played for other countries.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. [email protected]

You may unsubscribe at any time using the link in our newsletter.